NASDAQ · Medical - Diagnostics & Research

FLGT (FLGT) Stock

$18.53 -0.11% NASDAQ: FLGT Healthcare

Valuation

MetricValue
Price$18.53
Market Cap$526.26M
P/E Ratio-8.10
P/B Ratio0.41
P/S Ratio1.42
EPS (TTM)$-1.97
52-Week High$31.04
52-Week Low$13.46
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.49%
ROA-5.02%
ROCE-8.22%
Gross Margin-28.17%
Operating Margin-28.17%
Net Margin-23.04%
Debt/Equity0.01
Current Ratio6.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$993.0M$619.0M$289.0M$283.0M$323.0M
Operating Profit$676.0M$179.0M$-196.0M$-74.0M$-91.0M
Net Profit$507.0M$143.0M$-168.0M$-43.0M$-61.0M
EPS$16.26$4.63$-5.63$-1.41$-1.97
Op Margin68.1%28.8%-67.6%-26.1%-28.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.3B$1.4B$1.2B$1.2B$1.2B
Total Liabilities$113.0M$116.0M$102.0M$91.0M$107.0M
Cash$165.0M$80.0M$97.0M$55.0M$50.0M
Borrowings$21.0M$39.0M$15.0M$8.0M$8.0M

Latest News

Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 Business Wire · Jul 9, 2026 Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions Simply Wall St. · Jun 25, 2026 How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments Simply Wall St. · Jun 7, 2026 Fulgent Presents Updated FID-007 Data at ASCO 2026 Business Wire · Jun 1, 2026 Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ... GuruFocus.com · May 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$539.0M$254.0M$27.0M$21.0M$-102.0M
Investing Cash Flow$-570.0M$-280.0M$17.0M$-99.0M$89.0M
Financing Cash Flow$-4.0M$-76.0M$-28.0M$-3.0M$-14.0M
Net Cash Flow$77.0M$-85.0M$18.0M$-42.0M$-5.0M
Free Cash Flow$515.0M$235.0M$5.0M$-19.0M$-124.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-24.81%
Quick Ratio5.31
Interest Coverage—
Return 1Y5.83%
Return 3Y-50.01%
Return 5Y-73.30%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARVN $8.02 -3.43% -6.94 $517.14M 0.00%
AVXL $2.49 -3.11% -5.02 $230.75M 0.00%
BFLY $8.28 -1.72% -60.65 $2.20B 0.00%
CDNA $43.71 +14.72% 18.87 $2.26B 0.00%
CSTL $24.44 -0.99% -23.63 $741.26M 0.00%

About FLGT

FLGT is led by CEO Ming Hsieh, employs 1,313 people, headquartered in US, publicly traded since 2016.

FLGT stock trades at $18.53 with a market capitalization of $526.26M. The stock is valued at a price-to-earnings (P/E) ratio of -8.10, price-to-book of 0.41, price-to-sales of 1.42. Over the past 52 weeks the stock has ranged between $13.46 and $31.04, and currently trades 40.3% below its 52-week high.

On profitability, FLGT generates a return on equity (ROE) of -5.49%, return on capital employed of -8.22%, an operating margin of -28.17%, a net profit margin of -23.04%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides